J
José Luis Zamorano
Researcher at Carlos III Health Institute
Publications - 740
Citations - 154643
José Luis Zamorano is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 105, co-authored 695 publications receiving 133396 citations. Previous affiliations of José Luis Zamorano include Hospital Clínico San Carlos & Universidad Francisco de Vitoria.
Papers
More filters
Journal Article
Detection of Obstructive Coronary Artery Disease by Non Invasive Anatomical and Functional Imaging. Results of the Multicenter European EVINCI Study
Danilo Neglia,Daniele Rovai,Chiara Caselli,Philipp A. Kaufmann,Massimo Lombardi,Valentina Lorenzoni,Martina Marinelli,Stephan G. Nekolla,Mikko Pietilä,Arthur J. Scholte,Rosa Sicari,A. Teresinska,José Luis Zamorano,Richard S. Underwood,Juhani Knuuti,Evinci Investigators +15 more
Journal ArticleDOI
Ivabradine-Stimulated Microvesicle Release Induces Cardiac Protection against Acute Myocardial Infarction.
Rafael Ramirez-Carracedo,Rafael Ramirez-Carracedo,Laura Tesoro,Laura Tesoro,Ignacio Hernandez,Ignacio Hernandez,Javier Diez-Mata,Javier Diez-Mata,Laura Botana,Marta Saura,Marta Saura,Marcelo Sanmartín,José Luis Zamorano,Carlos Zaragoza,Carlos Zaragoza +14 more
TL;DR: In a porcine model of ischemia reperfusion (IR), Ivabradine induces cardiac protection by increasing at least the release of EMMPRIN containing cardiac microvesicles over Placebo.
Journal Article
The role of statins in aortic stenosis. Myth or reality
TL;DR: Determining the appropriate timing of statin therapy to slow the progression of bone formation in these lesions is essential for the routine use of these drugs in such patients.
Journal ArticleDOI
Linee guida ESC 2015 per il trattamento dell’endocardite infettiva. Task Force per il Trattamento dell’Endocardite Infettiva della Società Europea di Cardiologia (ESC)
Gilbert Habib,Patrizio Lancellotti,Manuel J. Antunes,Maria Grazia Bongiorni,Jean-Paul Casalta,Francesco Del Zotti,Raluca Elena Dulgheru,Gebrine El Khoury,Paola Anna Erba,Bernard Iung,José M. Miró,Barbara J.M. Mulder,E. Plonska-Gosciniak,Susanna Price,Jolien W. Roos-Hesselink,Ulrika Snygg-Martin,Franck Thuny,Pilar Tornos Mas,Isidre Vilacosta,José Luis Zamorano +19 more
Journal ArticleDOI
Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin.
TL;DR: The efficacy and safety of pitavastatin for the treatment of dyslipidaemia were reviewed, highlighting its further advantages beyond LDL-C reduction, and the impact of statins on the glycaemic profile was discussed.